NeuroMetrix, Inc. (NASDAQ:NURO – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.14 and traded as high as $4.52. NeuroMetrix shares last traded at $4.50, with a volume of 1,206 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com began coverage on shares of NeuroMetrix in a research report on Friday. They issued a “sell” rating for the company.
View Our Latest Stock Report on NURO
NeuroMetrix Stock Performance
Institutional Trading of NeuroMetrix
An institutional investor recently bought a new position in NeuroMetrix stock. Renaissance Technologies LLC purchased a new stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 11,560 shares of the medical device company’s stock, valued at approximately $46,000. Renaissance Technologies LLC owned about 0.57% of NeuroMetrix at the end of the most recent reporting period. 19.40% of the stock is owned by hedge funds and other institutional investors.
About NeuroMetrix
NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.
Further Reading
- Five stocks we like better than NeuroMetrix
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 03/24 – 03/28
- How Can Investors Benefit From After-Hours Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Canadian Penny Stocks: Can They Make You Rich?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for NeuroMetrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix and related companies with MarketBeat.com's FREE daily email newsletter.
